1,766 results match your criteria: "Aichi Medical University School of Medicine.[Affiliation]"

Article Synopsis
  • HLA-haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide (PTCy-haplo) is becoming a safer and more available option compared to matched unrelated donor (MUD) transplants for acute myeloid leukemia (AML).
  • * A nationwide study found that while PTCy-haplo has a slower hematopoietic recovery and higher infection-related deaths, it also shows lower rates of severe graft-versus-host disease (GVHD) compared to ATG-free MUD transplants.
  • * Overall survival rates were similar across all transplant types, suggesting that PTCy-haplo could be a viable option for AML patients lacking an HLA-matched donor.
View Article and Find Full Text PDF

This study retrospectively compared outcomes of various allogeneic haematopoietic cell transplantation (allo-HCT) platforms in patients with adult T-cell leukaemia/lymphoma. Platforms included human leukocyte antigen (HLA)-haploidentical-related donors using post-transplant cyclophosphamide (PTCY), HLA-matched related donors (MRD), HLA-matched unrelated donors (MUD) and cord blood transplantation (CBT). Patients who underwent their first allo-HCT between 2016 and 2021 were included.

View Article and Find Full Text PDF

Background: People differ in their preferred time for intellectual activities. Morningness-eveningness preferences describe the preferred time for performing daily activities and are determined by chronotype. Chronotype reflects circadian preference in humans and is divided into morning, intermediate, and evening types.

View Article and Find Full Text PDF

The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell transplant (HSCT) activity in the World Health Organization (WHO) Eastern Mediterranean Region (EMRO). Participating countries, including Pakistan, Oman, Iran, and Saudi Arabia, reported increased HSCT in the last few years, whereas others from the EMRO and beyond, including Qatar, United Arab Emirates, Nepal, and Bangladesh, started HSCT recently and have developed HSCT programs with excellent results. During educational sessions and open dialog, participating teams and international experts from the WBMT shared their experience and discussed minimum essential requirements for establishing and expanding HSCT in emerging countries, indications for HSCT training and dissemination of knowledge, stem cell donor selection and safety, quality assurance in transplant centers, and the value and importance of transplant outcome databases.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess how hypertensive disorders of pregnancy affect the risk of cerebral palsy (CP) and developmental delay (DD) in very low-birth-weight infants born at 24-31 weeks gestation.
  • - Among the 529 VLBW infants analyzed, 56.1% were followed for CP and 54.1% for DD, revealing that infants with CP had significantly lower rates of hypertensive disorders compared to controls.
  • - The research concluded that conditions like preeclampsia may be linked to a lower incidence of CP, whereas infants with DD showed higher rates of serious health complications compared to controls.
View Article and Find Full Text PDF
Article Synopsis
  • Autologous peripheral blood stem cell (PBSC) transplantation is a common treatment for conditions like multiple myeloma and lymphomas, and it usually involves freezing the stem cells before transplant.* -
  • A recent systematic review of 19 transplant centers that performed non-cryopreserved PBSC transplants showed that the procedure is feasible and safe, with high stem cell viability and low rates of complications.* -
  • The study found that stem cell viability was over 90% for multiple myeloma and over 75% for lymphomas, with quick engraftment times, and only 1% transplant-related mortality within 100 days.*
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of the fludarabine/intravenous busulfan (FB4) regimen in patients with myelodysplastic syndrome (MDS) undergoing stem cell transplantation from unrelated donors, comparing FB4 alone, FB4 with anti-thymoglobulin (ATG), and FB4 with low-dose total body irradiation (TBI).
  • Results show that the combination of FB4 with low-dose ATG significantly improved overall survival (OS) and reduced nonrelapse mortality (NRM) compared to FB4 alone, whereas the FB4 with TBI did not demonstrate notable advantages over the FB4 regimen.
  • The study highlights that using FB4 plus low-dose ATG is associated with better outcomes
View Article and Find Full Text PDF
Article Synopsis
  • Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can lead to long-lasting remission in adult T-cell leukemia/lymphoma (ATL) patients, but there's a lack of research on post-transplant outcomes for younger patients (≤49 years).
  • A study found that patients aged <40 years had a significantly better overall survival rate (61.8%) compared to those aged 40-49 years (43.1%), indicating younger patients fare better post-transplant.
  • Moreover, while there were no major differences in survival outcomes between different conditioning regimens, the reduced-intensity conditioning (RIC) regimen resulted in lower non-relapse mortality compared to the myeloablative conditioning (MAC) regimen
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzing hospital records from 208 hospitals in Japan from 2011 to 2020 found that malignant neoplasms (cancers) were the leading cause of death for diabetic patients (38.9%), followed by infectious diseases (17.0%) and vascular diseases (10.9%).
  • Diabetic patients had significantly higher mortality rates from cancers, infections, renal failure, and ischemic heart diseases compared to non-diabetic patients, while cerebrovascular disease deaths were lower among diabetics.
  • The causes of death varied by age in diabetics, with malignant neoplasms being the most common across all age groups, and infectious diseases most prevalent in those over 70, while ischemic heart disease was most common in
View Article and Find Full Text PDF

Systemic corticosteroid therapy is a well-established first-line treatment for grades II-IV acute graft-versus-host disease (aGVHD). Recently, several developments have occurred, including the introduction of transplantation from human leukocyte antigen (HLA) haploidentical donors using post-transplant cyclophosphamide (PTCY-Haplo), and improvements in prognosis after cord blood transplantation (CBT) in Japan. This study aimed to analyze the association between donor sources and outcomes in patients with aGVHD.

View Article and Find Full Text PDF
Article Synopsis
  • The SIMPLIFY Japan study examined the transition from multiple daily insulin injections to once-daily iGlarLixi in adults with moderately controlled type 2 diabetes (T2D).
  • Over 24 weeks, participants showed significant improvements in health-related quality of life (HRQOL) scores, particularly in areas related to daily activities and treatment satisfaction, with minimal negative impact on glycemic control.
  • Additionally, there was an increase in treatment adherence and a small weight reduction, but incidences of hypoglycemia and gastrointestinal side effects were noted among participants.
View Article and Find Full Text PDF

Mucosal-associated invariant T cells (MAIT cells) are a subset of T cells with innate, effector-like properties that play an essential role in the immune response to microbial infections. In humans, MAIT cells are detectable in the blood, liver, and lungs, but little is known about the frequency of these cells in the bone marrow. Also, the pathogenic role, if any, of MAIT cells in the development of aplastic anemia, a disease with an exquisite origin in the bone marrow, is currently unknown.

View Article and Find Full Text PDF
Article Synopsis
  • * A study using data from the Japanese nationwide transplantation registry assessed 857 patients with relapsed or refractory non-Hodgkin lymphoma, with 169 receiving PTCY-haplo and 688 receiving uCBT, revealing no significant differences in overall survival, progression-free survival, or graft-versus-host disease-free/relapse-free survival between the two groups.
View Article and Find Full Text PDF

Diagnosing the cause of death can be challenging, particularly for patients with no prior history of visits to the treating hospital. We encountered a case involving a 76-year-old male who was discovered in a state of cardiopulmonary arrest at his home and subsequently declared deceased in our hospital due to severe pneumonia. He had exhibited symptoms of fever over 37°C and severe coughing for several days.

View Article and Find Full Text PDF
Article Synopsis
  • The ALL-R08 study in Japan focuses on children with first-relapsed acute lymphoblastic leukemia (ALL) to evaluate the effectiveness of the BFM-S classification and measurable residual disease (MRD) as prognostic tools for patient survival.
  • The study consists of two parts: an observational study (ALL-R08-I) and a clinical trial (ALL-R08-II) that differentiates treatment based on MRD levels after induction therapy.
  • Results showed varying 3-year event-free survival rates across different BFM-S groups, indicating that children treated with either Japanese or BFM-type protocols have similar outcomes for managing first-relapsed ALL.
View Article and Find Full Text PDF

Recently, there has been a significant increase in the utilization of self-expandable metallic stents (SEMSs) for treating malignant colorectal obstructions through colorectal stenting. The mechanical properties of SEMSs are usually considered to affect clinical outcomes of patients with malignant colorectal obstructions. : This single-arm, prospective, multicenter study of SEMS with a lower axial force and high axial force zero-border included 200 patients with malignant colorectal obstruction.

View Article and Find Full Text PDF

The objectives were to investigate the clinical characteristics and course of long COVID, defined as the persistence of symptoms at least one month after the onset of COVID-19, in outpatients and to clarify differences in symptoms between SARS CoV-2 mutant strains. Our observational study in a primary care institution in Japan included 1053 patients with long COVID who visited our outpatient clinic between April 2021 and March 2023. Symptom distribution, performance status, and patient background at the time of the first outpatient visit were compared between infectious strains (Delta and before group and Omicron group).

View Article and Find Full Text PDF

Background: To investigate whether the addition of eltrombopag (EPAG) to rabbit anti-thymocyte globulin (ATG)-based immunosuppressive therapy (IST) for newly diagnosed severe aplastic anemia (SAA) improves outcomes and affects the cumulative incidence of clonal evolution (CE), we conducted a multicenter retrospective analysis.

Methods: Data were collected from 101 patients, aged 15 - 65 years, undergoing initial IST.

Results: No significant imbalance in age, sex, or severity was observed between the EPAG (n = 20) and non-EPAG (n = 81) groups.

View Article and Find Full Text PDF

Detecting antibodies, particularly those targeting donor human leukocyte antigens in organ transplantation and self-antigens in autoimmune diseases, is crucial for diagnosis and therapy. Radioprotective 105 (RP105), a Toll-like receptor family protein, is expressed in immune-competent cells, such as B cells. Studies in mice have shown that the anti-mouse RP105 antibody strongly activates B cells and triggers an adjuvant effect against viral infections.

View Article and Find Full Text PDF

Despite widespread cervical cancer (CC) screening programs, low participation has led to high morbidity and mortality rates, especially in developing countries. Because early-stage CC often has no symptoms, a non-invasive and convenient diagnostic method is needed to improve disease detection. In this study, we developed a new approach for differentiating both CC and cervical intraepithelial neoplasia (CIN)2/3, a precancerous lesion, from healthy individuals by exploring CC fatty acid metabolic reprogramming.

View Article and Find Full Text PDF

Individuals suffering from diabetic polyneuropathy (DPN) experience debilitating symptoms such as pain, paranesthesia, and sensory disturbances, prompting a quest for effective treatments. Dipeptidyl-peptidase (DPP)-4 inhibitors, recognized for their potential in ameliorating DPN, have sparked interest, yet the precise mechanism underlying their neurotrophic impact on the peripheral nerve system (PNS) remains elusive. Our study delves into the neurotrophic effects of DPP-4 inhibitors, including Diprotin A, linagliptin, and sitagliptin, alongside pituitary adenylate cyclase-activating polypeptide (PACAP), Neuropeptide Y (NPY), and Stromal cell-derived factor (SDF)-1a-known DPP-4 substrates with neurotrophic properties.

View Article and Find Full Text PDF

Heart failure affects millions of people worldwide, with men exhibiting a higher incidence than women. Our previous work has shown that mosaic loss of the Y chromosome (LOY) in leukocytes is causally associated with an increased risk for heart failure. Here, we show that LOY macrophages from the failing hearts of humans with dilated cardiomyopathy exhibit widespread changes in gene expression that correlate with cardiac fibroblast activation.

View Article and Find Full Text PDF

This study aimed to develop a prostatic pharmacokinetic model of ceftazidime and suggest more effective dosing strategy for the bacterial prostatitis, based on a site-specific pharmacokinetic and pharmacodynamic perspective. Subjects were prostatic hyperplasia patients prophylactically receiving a 0.5-h infusion of 1.

View Article and Find Full Text PDF